TIDMGSK

RNS Number : 5214Y

GlaxoSmithKline PLC

09 September 2020

   GlaxoSmithKline plc   (the ' Company ') 

Transaction notification

 
 1.    Details of PDMR/person closely associated with them ('PCA') 
====  ============================================================================================== 
 a)    Name                                   Mr L Miels 
====  ======================================  ====================================================== 
 b)    Position/status                        President, Global Pharmaceuticals 
====  ======================================  ====================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ====================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ====================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ====================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ====================================================== 
 b)    Nature of the                          Following the vesting on 4 September 2020 
        transaction                            of 25% of an award made on 14 February 
                                               2018 under the GlaxoSmithKline Deferred 
                                               Investment Award Plan, Mr Miels will receive 
                                               a cash payment of GBP373,151.97 less applicable 
                                               tax withholding in respect of 25,999.998 
                                               notional Ordinary Shares. 
====  ======================================  ====================================================== 
 c)    Price(s) and                            Price(s)                  Volume(s) 
        volume(s) 
====  ======================================   ========================  ========================= 
   GBP14.352                                                             25,999.998 
   ====================================================================  ========================= 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =================================================================  ================================ 
 e)    Date of the transaction                2020-09-04 
====  ======================================  ====================================================== 
 f)    Place of the                           N/A 
        transaction 
====  ======================================  ====================================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHZKLFBBKLFBBB

(END) Dow Jones Newswires

September 09, 2020 10:11 ET (14:11 GMT)

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Gsk.
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Gsk.